American Century Companies’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Buy
15,273
+4,633
+44% +$130K ﹤0.01% 2620
2026
Q1
$304K Sell
10,640
-70,972
-87% -$2.42M ﹤0.01% 2635
2025
Q4
$3.23M Buy
81,612
+8,727
+12% +$320K ﹤0.01% 1911
2025
Q3
$2.57M Buy
72,885
+39,381
+118% +$1.36M ﹤0.01% 1972
2025
Q2
$1.1M Buy
33,504
+16,632
+99% +$540K ﹤0.01% 2256
2025
Q1
$544K Hold
16,872
– – ﹤0.01% 2478
2024
Q4
$516K Buy
+16,872
New +$543K ﹤0.01% 2499
2022
Q2
– Sell
-8,887
Closed -$571K – 2311
2022
Q1
$571K Hold
8,887
– – ﹤0.01% 1903
2021
Q4
$618K Sell
8,887
-147
-2% -$10.7K ﹤0.01% 1841
2021
Q3
$628K Hold
9,034
– – ﹤0.01% 1792
2021
Q2
$717K Buy
+9,034
New +$657K ﹤0.01% 1704

Other funds holding ATRC

American Century Companies's ATRC Position: Q2 2026 in Review

American Century Companies increased its AtriCure (ATRC) stake by 44% in Q2 2026, buying an estimated $130K and bringing the position to 15,273 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

American Century Companies first reported a position in ATRC in Q2 2021 and has held it in 11 quarters since. The position peaked at $3.23M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • American Century Companies held 15,273 shares of AtriCure worth $427K as of Q2 2026.
  • American Century Companies bought 4,633 AtriCure shares in Q2 2026, an estimated $130K.
  • AtriCure made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2620 holding.
  • American Century Companies first reported a position in AtriCure in Q2 2021 and has held it in 11 quarters since.
  • American Century Companies's AtriCure position peaked at $3.23M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.